<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mouchlis, V. D.</style></author><author><style face="normal" font="default" size="100%">Barbayianni, E.</style></author><author><style face="normal" font="default" size="100%">Mavromoustakos, T. M.</style></author><author><style face="normal" font="default" size="100%">Kokotos, G.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The application of rational design on phospholipase A2 inhibitors</style></title><secondary-title><style face="normal" font="default" size="100%">Current Medicinal Chemistry</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-79957960050&amp;doi=10.2174%2f092986711795933678&amp;partnerID=40&amp;md5=7a46b9da619a4a6ad4eb6c1fe5d12d3f</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">18</style></volume><pages><style face="normal" font="default" size="100%">2566 - 2582</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">17</style></issue><notes><style face="normal" font="default" size="100%">Cited By :18Export Date: 23 August 2017</style></notes></record></records></xml>